To exclude the possibility that ARA-C's modulation of the EWS/FLI signature was simply a nonspecific response to treatment with all cytotoxic agents, we asked whether other compounds known to kill Ewing sarcoma cells would induce the EWS/FLI off genome-wide expression pattern. The gene discussed is EWSR1; the disease is Ewing sarcoma.